BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2779949)

  • 21. Genetically determined regulators acting on the blast cells of acute myeloblastic leukemia.
    McCulloch EA; Minden MD; Kelleher C; Miyauchi J; Wang C; Cheng GY
    Acta Haematol; 1987; 78 Suppl 1():18-25. PubMed ID: 2829486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivities of AML blast stem cells to idarubicin and daunorubicin: a comparison with normal hematopoietic progenitors.
    Curtis JE; Minden MD; Minkin S; McCulloch EA
    Leukemia; 1995 Mar; 9(3):396-404. PubMed ID: 7533865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of vesnarinone, a quinolinone derivative, on the growth of leukemic blasts in acute myelogenous leukemia.
    Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S
    Exp Hematol; 1997 Mar; 25(3):199-204. PubMed ID: 9091294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia.
    Yang GS; Minden MD; McCulloch EA
    Leukemia; 1994 Dec; 8(12):2065-75. PubMed ID: 7807996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies of leukemic blast progenitors from acute myeloblastic leukemia patients in viscid methylcellulose culture and liquid suspension culture].
    Nara N
    Rinsho Ketsueki; 1986 May; 27(5):651-8. PubMed ID: 3528561
    [No Abstract]   [Full Text] [Related]  

  • 26. Cellular and pharmacologic aspects of drug resistance in acute myeloid leukemia.
    Ross DD
    Curr Opin Oncol; 1991 Feb; 3(1):21-9. PubMed ID: 1675126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia.
    Ho MM; Hogge DE; Ling V
    Exp Hematol; 2008 Apr; 36(4):433-42. PubMed ID: 18249061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of humoral and cellular factors on the growth of blast progenitors of acute myeloblastic leukemia in serum-free culture.
    Maruyama Y; Tohda S; Nagata K; Suzuki T; Murohashi I; Nara N
    Hematol Pathol; 1990; 4(3):115-23. PubMed ID: 1701766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of cytokines in the proliferation of leukemia cells in acute myelogenous leukemia].
    Nara N
    Rinsho Byori; 1993 Dec; 41(12):1289-95. PubMed ID: 7507532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro effects of bisantrene on fresh clonogenic leukemia cells: a preliminary study on 15 cases.
    Visani G; Rizzi S; Tosi P; Cenacchi A; Gamberi B; Lemoli RM; Papadopulu P; Tura S
    Haematologica; 1990; 75(6):527-31. PubMed ID: 2098293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-6 reduces the optimal growth in vitro of leukemic blast progenitors from acute myeloblastic leukemia patients.
    Suzuki T; Bessho M; Hirashma K; Tohda S; Nagata K; Imai Y; Nara N
    Acta Haematol; 1992; 87(1-2):63-8. PubMed ID: 1374992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of acute myeloblastic leukemia (AML) cell proliferation and blast colony formation by antisense oligomer for IL-1 beta converting enzyme (ICE) and IL-1 receptor antagonist (IL-1ra).
    Stosić-Grujicić S; Basara N; Milenković P; Dinarello CA
    J Chemother; 1995 Feb; 7(1):67-70. PubMed ID: 7629564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of platelet-derived growth factor on the proliferation of blast progenitors from acute myeloblastic leukemia patients.
    Nara N; Tohda S; Nagata K; Suzuki T; Yamashita Y; Imai Y
    Acta Haematol; 1990; 83(4):187-92. PubMed ID: 2115715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity in acute myeloblastic leukemia.
    McCulloch EA; Kelleher CA; Miyauchi J; Wang C; Cheng GY; Minden MD; Curtis JE
    Leukemia; 1988 Dec; 2(12 Suppl):38S-49S. PubMed ID: 3199879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity to 5-azacytidine of blast progenitors in acute myeloblastic leukemia.
    Wang C; McCulloch EA
    Blood; 1987 Feb; 69(2):553-9. PubMed ID: 2432971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of recombinant human M-CSF on the proliferation of leukemic blast progenitors in AML patients.
    Suzuki T; Nagata K; Murohashi I; Nara N
    Leukemia; 1988 Jun; 2(6):358-62. PubMed ID: 3287022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia.
    Cannistra SA; Groshek P; Griffin JD
    Leukemia; 1989 May; 3(5):328-34. PubMed ID: 2654494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normal and leukemic hemopoiesis compared.
    McCulloch EA; Buick RN; Till JE
    Cancer; 1978 Aug; 42(2 Suppl):845-53. PubMed ID: 278636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: significance for response to chemotherapy.
    Hu ZB; Minden MD; McCulloch EA
    Leukemia; 1996 Mar; 10(3):410-6. PubMed ID: 8642855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.